APA (7th ed.) Citation

M, S., A, B., M, G., A, M., A, C., M, C., . . . M, J. (2025). Lymphocyte Inhibition Mechanisms and Immune Checkpoints in COVID-19: Insights into Prognostic Markers and Disease Severity. Medicina (Kaunas, Lithuania), 61(2), . https://doi.org/10.3390/medicina61020189

Chicago Style (17th ed.) Citation

M, Schniederova, Bobcakova A, Grendar M, Markocsy A, Ceres A, Cibulka M, Dobrota D, and Jesenak M. "Lymphocyte Inhibition Mechanisms and Immune Checkpoints in COVID-19: Insights into Prognostic Markers and Disease Severity." Medicina (Kaunas, Lithuania) 61, no. 2 (2025). https://doi.org/10.3390/medicina61020189.

MLA (9th ed.) Citation

M, Schniederova, et al. "Lymphocyte Inhibition Mechanisms and Immune Checkpoints in COVID-19: Insights into Prognostic Markers and Disease Severity." Medicina (Kaunas, Lithuania), vol. 61, no. 2, 2025, https://doi.org/10.3390/medicina61020189.